UTILIZING METFORMIN TO ENHANCE THE EFFICACY OF ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF PROSTATE CANCER.

被引：0
|
作者：
Colquhoun, Alexandra
Venier, Natalie
Fleshner, Neil
Pollak, Michael
Klotz, Laurence
Venkateswaran, Vasundara
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.148
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
99
引用
收藏
页码：E41 / E41
页数：1
相关论文
共 50 条
  • [21] Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer
    Hess-Wilson, Janet K.
    CANCER CAUSES & CONTROL, 2009, 20 (07) : 1029 - 1037
  • [22] Cabozantinib plus androgen deprivation therapy in patients with androgen-dependent metastatic prostate cancer.
    Corn, Paul Gettys
    Zurita, Amado J.
    Subudhi, Sumit Kumar
    Tu, Shi-Ming
    Aparicio, Ana
    Araujo, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [23] Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer
    Janet K. Hess-Wilson
    Cancer Causes & Control, 2009, 20 : 1029 - 1037
  • [24] The influence of androgen deprivation therapy on physical and cognitive function in men with prostate cancer.
    van Londen, G.
    Levy, M.
    Perera, S.
    Studenski, S.
    Greenspan, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S144 - S144
  • [25] Androgen deprivation therapy in localized prostate cancer. Current status and future trends
    Rivas, J. Gomez
    Fernandez, L.
    Abad-Lopez, P.
    Moreno-Sierra, J.
    ACTAS UROLOGICAS ESPANOLAS, 2023, 47 (07): : 398 - 407
  • [26] Alendronate prevents bone loss in men on androgen deprivation therapy for prostate cancer.
    Greenspan, SL
    Wagner, JM
    Nelson, JB
    Resnick, NM
    Parker, RA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S93 - S93
  • [27] LH-receptor polymorphisms and response to androgen deprivation therapy in prostate cancer.
    Liu, S. V.
    Dorff, T. B.
    Wang, Q.
    Xiong, S.
    Thara, E.
    Keng, M.
    Ingles, S. A.
    Pinski, J. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Androgen deprivation treatment in prostate cancer
    Thomas, Benjamin C.
    Neal, David E.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [29] UPDATE ON ANDROGEN DEPRIVATION THERAPY AND ADJUVANT METFORMIN (ADMET) TRIAL FOR MEN WITH TREATMENT NAIVE METASTATIC PROSTATE CANCER
    Rhee, Handoo
    Gunter, J.
    Jovanovic, L.
    Williams, E.
    Hollier, B.
    Vela, I.
    Wood, S.
    Ho, K.
    Nelson, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 40 - 41
  • [30] High efficacy of combination therapy of PI3K/AKT inhibitors with androgen deprivation in prostate cancer.
    Marques, Rute
    Aghai, Ashraf
    Stuurman, Debra
    de Ridder, Corrina
    Boer, Agnes
    Hoeben, Sander
    Trapman, Jan
    van Weerden, Wytske M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345